Venclexta is a prescription drug that costs approximately $97 for each 100mg tablet in the US. The price of Venclexta | Venetoclax in India is far less than it is in the US. Abbvie has negotiated rights to market this drug outside of the US. The generic version of Venclexta is now available in India. The Food and Drug Administration has described it as a “breakthrough discovery” for the treatment of chronic lymphocytic leukemia, small lymphocytic lymphoma and recently acute myeloid leukemia.
Venclexta 100mg, 120 tablets is available for $1750, shipping included.
Please contact us 24/7 at our US number 1-858-952-1077.
Our health advocates will be taking your call. We have helped 100s of patient find treatment for the fraction of the price in the US. Purchases of 3 bottles of more receive 5% discount. venclexta price in india
Venetoclax is a prescription medication to treat CLL or chronic lymphocytic leukemia for those who were not receptive to first attempt at treatment. Acute myeloid leukemia (AML) and small lymphocytic lymphona responds well to this treatment. Venetoclax is available in 10mg, 50mg and 100mg tablets.
Venetoclax is the patented chemical name of Venclexta.
It is the second line of treatment for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
Venetoclax Side Effects:
Most common side effects of venetoclax are low blood cell count, fatigue, upper respiratory tract infection, diarrhea, anemia and low platelet count.
Some patients experience these major side effects like tumor lysis syndrome and severe low white blood cell count.
Male patients on venetoclax sometimes can experience fertility problems.
What to avoid when taking Venclexta or Venclyxto?
The following will increase venetoclax/Venclexta in your blood:
- Grapefruit juice
- Seville oranges (often used in marmalade)
What is patient profile of chronic lymphocytic leukemia or CLL?
CLL accounts for 37% of all cases of leukemia in adults. The average age of a patient diagnosed with CLL is 70 years of age, more common in older adults. 12,990 men and 7,950 women will be diagnosed for CLL this year.
What is the patient survival rate after diagnosis of chronic lymphocytic leukemia or CLL?
Compared to other cancers CLL has a higher survival rate. On average a CLL patient after diagnosis will be alive for 5 years. However, some patients may live longer due to on and off treatment because CLL recurs.
Have any questions give Sunny Pharma a call 24/7 at 858-952-1077 or fill the form and we will get back to your right away.